Literature DB >> 10374003

The folly of population screening for type 2 diabetes.

K G Marshall.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10374003      PMCID: PMC1230366     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  Notes of a biology-watcher The Health-care system.

Authors:  L Thomas
Journal:  N Engl J Med       Date:  1975-12-11       Impact factor: 91.245

2.  The ethics of prevention: old twists and new.

Authors:  J Herman
Journal:  Br J Gen Pract       Date:  1996-09       Impact factor: 5.386

Review 3.  Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-07-15       Impact factor: 8.262

4.  The paradox of health.

Authors:  A J Barsky
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

Review 5.  Validation of screening procedures.

Authors:  A L Cochrane; W W Holland
Journal:  Br Med Bull       Date:  1971-01       Impact factor: 4.291

6.  The ultimate triumph of obesity.

Authors:  J Foreyt; K Goodrick
Journal:  Lancet       Date:  1995-07-15       Impact factor: 79.321

7.  The last well person.

Authors:  C K Meador
Journal:  N Engl J Med       Date:  1994-02-10       Impact factor: 91.245

8.  Reframing the debate on health care reform by replacing our metaphors.

Authors:  G J Annas
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

9.  The tyranny of health.

Authors:  F T Fitzgerald
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

Review 10.  Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-08-15       Impact factor: 8.262

View more
  4 in total

1.  Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.

Authors:  H C Gerstein; S Meltzer
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.

Authors:  J Mahon
Journal:  CMAJ       Date:  2000-04-04       Impact factor: 8.262

Review 3.  The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.

Authors:  Andrew W Lyon; Erik T Larsen; Alun L Edwards
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

4.  Undiagnosed diabetes: does it matter?

Authors:  T K Young; C A Mustard
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.